Development and Validation of Novel RP-HPLC Method for the Simultaneous Determination of Remogliflozin and Vildagliptin in Bulk and in synthetic Mixture
Drashti A. Mandale, Chainesh Shah & Rakesh Jatt · Journal of Pharmaceutical Research International · 2021
Vildagliptin which is DPP-4 inhibitor and Remogliflozin which is SGLT2 inhibitor in single dose regimen lower blood glucose by separate, complementary mechanisms. Both are glucose dependent, accounting for the low risk of hypoglycaemia during treatment. There is no risk factors a...
Open access
Research Article
10.9734/jpri/2021/v33i40B32296